Professor Gu Zhen and student researchers at the Zhejiang University College of Pharmaceutical Sciences in Zhejiang, China are at the forefront of research. President Xi Jinping of China has a strong desire for independence from the West. This was highlighted when President Trump imposed restrictions on Huawei, a telecoms giant, purchasing U.S. tech in 2019. This move confirmed the long-standing anxieties among Chinese Communist Party leaders about being too reliant on American and Western high-tech imports.
For years, CCP leaders have emphasized the importance of being “self-reliant” in critical technologies like microchips. This desire for independence from the West has led to increased efforts in research and development within China. Professor Gu Zhen and their team of student researchers are working tirelessly at Zhejiang University to push boundaries and innovate in the field of pharmaceutical sciences.
Their dedication and hard work are evident in the groundbreaking research being conducted at the college. Despite challenges and restrictions imposed by Western powers, the team remains focused on advancing technology and innovation within China. The drive for independence from the West continues to fuel their passion and drive to make significant contributions to the field. The research being conducted at Zhejiang University College of Pharmaceutical Sciences is paving the way for a future where China can stand on its own in the realm of high-tech innovation.